Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dacomitinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dacomitinib 15mg tablets
0801050CQAAAAAA
|
Dacomitinib | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Dacomitinib 30mg tablets
0801050CQAAABAB
|
Dacomitinib | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Dacomitinib 45mg tablets
0801050CQAAACAC
|
Dacomitinib | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Vizimpro 15mg tablets
0801050CQBBAAAA
|
Vizimpro | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Vizimpro 30mg tablets
0801050CQBBABAB
|
Vizimpro | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Vizimpro 45mg tablets
0801050CQBBACAC
|
Vizimpro | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.